Project details
American clinical-stage life sciences company seeks investments
| Project region | United States |
|---|---|
| Industry | Healthcare |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | USD 29.5 billion 2020 market value - 11.4% expected CAGR |
|---|---|
| Project description |
The American company develops rapid diagnostics for the detection of any upper respiratory tract viral infection including all COVID. The global point-of-care-testing (POCT) market size in 2020 is valued at USD 29.5 billion and is expected to grow at a compound annual growth rate (CAGR) of 11.4% till 2025. Now the company seeks investments. |
We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.
Have Any Questions?
Reach out to our local experts, we’ll respond within one business day.
Our Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us
